Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and nsc 95397

moxifloxacin has been researched along with nsc 95397 in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(nsc 95397)		Trials
(nsc 95397)		Recent Studies (post-2010) (nsc 95397)
3,1575521,69034019

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)nsc 95397 (IC50)
Apoptotic peptidase activating factor 1Homo sapiens (human)12.7
toll-like receptor 9Homo sapiens (human)1.869
caspase-9 isoform alpha precursorHomo sapiens (human)9.83
caspase-3 isoform a preproproteinHomo sapiens (human)9.83
rac GTPase-activating protein 1 isoform aHomo sapiens (human)32.49
cysteine protease ATG4B isoform aHomo sapiens (human)12.8
hexokinase HKDC1Homo sapiens (human)5.63
Protein kinase C alpha typeHomo sapiens (human)1
Protein-glutamine gamma-glutamyltransferase 2Homo sapiens (human)1
M-phase inducer phosphatase 1Homo sapiens (human)2.2445
M-phase inducer phosphatase 2Homo sapiens (human)1.1937
M-phase inducer phosphatase 3Homo sapiens (human)0.0674
Histamine H1 receptorCavia porcellus (domestic guinea pig)3.77
Tyrosine-protein kinase JAK3Homo sapiens (human)1
Receptor-type tyrosine-protein phosphatase etaHomo sapiens (human)1
Receptor protein-tyrosine kinase Homo sapiens (human)1
large T antigenBetapolyomavirus macacae26.63
putative polyprotein4.7465

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW1

Other Studies

1 other study(ies) available for moxifloxacin and nsc 95397

ArticleYear
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors

2021